Overview
GEMZAR INJECTION 1gm vial contains Gemcitabine, an antineoplastic agent used primarily in the treatment of various cancers, including pancreatic, breast, and non-small cell lung cancer. This chemotherapy medication works by inhibiting the growth of cancer cells, thereby helping to control the spread of the disease.

Benefits

Effective in treating multiple types of cancer.
Can be used alone or in combination with other chemotherapy agents.
Helps to slow down cancer progression and improve survival rates.
Administered intravenously for better absorption and efficacy.


Dosage
The dosage of GEMZAR is determined by a healthcare professional based on the patient's condition, body surface area, and response to treatment. Typically, it is administered once a week for three weeks followed by a one-week rest period. Always follow the prescribed regimen provided by your healthcare provider.

Side Effects
Common side effects of GEMZAR may include:

Nausea and vomiting
Fatigue
Hair loss
Low blood cell counts, leading to increased risk of infection and bleeding

Serious side effects are rare but can occur. It is important to contact a healthcare professional immediately if you experience severe symptoms such as difficulty breathing, swelling, or unusual bleeding.

FAQs
Is GEMZAR safe during pregnancy?
GEMZAR is not recommended for use during pregnancy as it may harm the fetus. Consult your doctor for alternatives if you are pregnant or planning to become pregnant.

Can GEMZAR be used in combination with other drugs?
Yes, GEMZAR can be used in combination with other chemotherapy agents. Your healthcare provider will determine the best treatment plan based on your specific situation.

How is GEMZAR administered?
GEMZAR is administered intravenously by a healthcare professional. It is important to follow the treatment schedule as prescribed.